The Asia Pacific intrauterine contraceptive device market is predicted to grow at the highest CAGR of 4.20% over the forecast period of 2017-2025, generating $1832 million by the end of 2025. Nations like China, India, Japan, and South Korea along with the rest of Asia-Pacific were researched for this market. It was established that China has the highest potential to flourish in the Asia-Pacific region. The market is segmented on the basis of products and types.

ASIA PACIFIC CONTRACEPTIVE MARKET FORECAST 2019-2027

Asia Pacific Contraceptive Market by Education (Less Than High School, High School Graduate, College Graduate, Other College Degrees) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End-user (Households, Clinics, Hospitals) by Drugs and Devices (Contraceptives Drugs, Contraceptive Devices) by Geography.

Request free sample

Report Summary

The contraceptives are available in the form of devices or medication drugs for inhibiting pregnancy, the transmission of sexually transmitted infections, and birth control & family planning. Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life.

The Asia Pacific contraceptive market is estimated to grow from $XX billion in 2018 to $XX billion by 2027, at a CAGR of 7.67% during the forecasting years of 2019-2027.

The use of advanced contraceptive methods and emergency contraceptives method, especially for teenagers and increase in awareness regarding sexually transmitted infections (STIs), are the major factors responsible for the growth of the contraceptives market. The economies of China, India, Japan, South Korea, Australia and the remaining countries collectively forming the Rest of Asia Pacific are the major influencers of the APAC contraceptive market. For decades, female sterilization has been the most popular form of contraception in India, and it remains so today. It is one of the reasons why the country is expected to have the fastest growth rate by the end of the forecasting period.

The Asia-Pacific contraceptives market is on a continuous rise due to the increase in the need for contraceptives in developing economies. The main challenge that has been reported in this region is providing sexual health information & services to an inappropriate population. Several initiatives are taken by the government to help increase awareness among the population, and coupled with the open conferences organized by them are the major factors that drive the market growth.

Bayer AG, Teva Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Okamoto Industries, Inc., OCON Medical Ltd., Afaxys, Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Pfizer, Inc., Church & Dwight Co., Inc., Cooper Surgical Inc., Allergan Inc., Reckitt Benckiser PLC, Agile Therapeutics, and Pregna are the major companies that are mentioned in the report.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Table of Contents

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • COLLEGE GRADUATE HOLDS THE LARGEST MARKET SHARE IN TERMS OF EDUCATION
        • AGE GROUP OF 15–24 YEARS IS ANTICIPATED TO GROW SIGNIFICANTLY
        • HOUSEHOLDS ARE THE MAJOR END-USER
        • CONTRACEPTIVES DEVICES ARE WIDELY USED
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • RISING CUSTOMER AWARENESS AND GOVERNMENT INITIATIVES
        • GROWING INCIDENCE OF UNWANTED PREGNANCIES
        • OCCURRENCE OF SEXUALLY TRANSMITTED DISEASES (STD)
      • MARKET RESTRAINTS
        • INCREASING AGING POPULATION
        • SIDE EFFECTS ASSOCIATED WITH THE USE OF CONTRACEPTIVE DRUGS AND DEVICES
      • MARKET OPPORTUNITIES
        • INCREASE IN AWARENESS AND IMPORTANCE REGARDING FAMILY PLANNING
        • STRATEGIC ALLIANCES AND INVESTING IN R&D
      • MARKET CHALLENGES
        • LACK OF PERCEPTION OF SOCIETY
        • INCREASING COST AND INACCESSIBILITY OF CERTAIN HEALTH SERVICES
    1. MARKET BY EDUCATION
      • LESS THAN HIGH SCHOOL
      • HIGH SCHOOL GRADUATE
      • COLLEGE GRADUATE
      • OTHER COLLEGE DEGREES
    2. MARKET BY AGE GROUP
      • 15–24 YEARS
      • 25–34 YEARS
      • 35–44 YEARS
      • ABOVE 44 YEARS
    3. MARKET BY END-USER
      • HOUSEHOLDS
      • CLINICS
      • HOSPITALS
    4. MARKET BY DRUGS AND DEVICES
      • CONTRACEPTIVES DRUGS
        • ORAL CONTRACEPTIVE PILLS
        • INJECTABLE CONTRACEPTIVES
        • TOPICAL CONTRACEPTIVES
      • CONTRACEPTIVE DEVICES
        • MALE CONDOMS
        • FEMALE CONDOMS
        • DIAPHRAGMS
        • CONTRACEPTIVE SPONGES
        • VAGINAL RINGS
        • SUBDERMAL IMPLANTS
        • INTRA-UTERINE DEVICES
          • COPPER INTRA-UTERINE DEVICES
          • HORMONAL INTRA-UTERINE DEVICES
    1. KEY ANALYTICS
      • PORTER’S FIVE FORCES MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIERS
        • THREAT OF COMPETITIVE RIVALRY
      • PESTEL ANALYSIS
      • MARKET TRENDS
      • OPPORTUNITY MATRIX
    2. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • JAPAN
        • CHINA
        • INDIA
        • AUSTRALIA
        • SOUTH KOREA
        • REST OF ASIA PACIFIC
    1. COMPETITIVE LANDSCAPE
      • MARKET POSITION ANALYSIS
      • COMPANY PROFILES
        • AFAXYS, INC.
        • AGILE THERAPEUTICS
        • ALLERGAN INC.
        • APOTHECUS PHARMACEUTICAL CORPORATION
        • BAYER AG
        • CHURCH & DWIGHT CO., INC.
        • COOPER SURGICAL INC.
        • MAYER LABORATORIES, INC.
        • MERCK & CO., INC.
        • OCON MEDICAL LTD.
        • OKAMOTO INDUSTRIES, INC.
        • PFIZER, INC.
        • PREGNA
        • RECKITT BENCKISER PLC
        • TEVA PHARMACEUTICAL INDUSTRIES LTD.

     

    TABLE LIST

    TABLE 1        ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    TABLE 2        ASSOCIATED SIDE EFFECTS FOR DIFFERENT CONTRACEPTIVE METHOD

    TABLE 3        ASIA PACIFIC CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

    TABLE 4        ASIA PACIFIC LESS THAN HIGH SCHOOL MARKET BY 2019-2027 ($ MILLION)

    TABLE 5        ASIA PACIFIC HIGH SCHOOL GRADUATE MARKET BY 2019-2027 ($ MILLION)

    TABLE 6        ASIA PACIFIC COLLEGE GRADUATE MARKET BY 2019-2027 ($ MILLION)

    TABLE 7        ASIA PACIFIC OTHER COLLEGE DEGREES MARKET BY 2019-2027 ($ MILLION)

    TABLE 8        ASIA PACIFIC CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

    TABLE 9        ASIA PACIFIC 15–24 YEARS MARKET BY 2019-2027 ($ MILLION)

    TABLE 10      ASIA PACIFIC 25–34 YEARS MARKET BY 2019-2027 ($ MILLION)

    TABLE 11      ASIA PACIFIC 35–44 YEARS MARKET BY 2019-2027 ($ MILLION)

    TABLE 12      ASIA PACIFIC ABOVE 44 YEARS MARKET BY 2019-2027 ($ MILLION)

    TABLE 13      ASIA PACIFIC CONTRACEPTIVE MARKET BY END-USER 2019-2027 ($ MILLION)

    TABLE 14      ASIA PACIFIC HOUSEHOLDS MARKET BY 2019-2027 ($ MILLION)

    TABLE 15      ASIA PACIFIC CLINICS MARKET BY 2019-2027 ($ MILLION)

    TABLE 16      ASIA PACIFIC HOSPITALS MARKET BY 2019-2027 ($ MILLION)

    TABLE 17      ASIA PACIFIC CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 18      ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY 2019-2027 ($ MILLION)

    TABLE 19      ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 20      ASIA PACIFIC ORAL CONTRACEPTIVE PILLS MARKET BY 2019-2027 ($ MILLION)

    TABLE 21      ASIA PACIFIC INJECTABLE CONTRACEPTIVES MARKET BY 2019-2027 ($ MILLION)

    TABLE 22      ASIA PACIFIC TOPICAL CONTRACEPTIVES MARKET BY 2019-2027 ($ MILLION)

    TABLE 23      ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY 2019-2027 ($ MILLION)

    TABLE 24      ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 25      ASIA PACIFIC MALE CONDOMS MARKET BY 2019-2027 ($ MILLION)

    TABLE 26      ASIA PACIFIC FEMALE CONDOMS MARKET BY 2019-2027 ($ MILLION)

    TABLE 27      ASIA PACIFIC DIAPHRAGMS MARKET BY 2019-2027 ($ MILLION)

    TABLE 28      ASIA PACIFIC CONTRACEPTIVE SPONGES MARKET BY 2019-2027 ($ MILLION)

    TABLE 29      ASIA PACIFIC VAGINAL RINGS MARKET BY 2019-2027 ($ MILLION)

    TABLE 30      ASIA PACIFIC SUBDERMAL IMPLANTS MARKET BY 2019-2027 ($ MILLION)

    TABLE 31      ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)

    TABLE 32      ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 33      ASIA PACIFIC COPPER INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)

    TABLE 34      ASIA PACIFIC HORMONAL INTRA-UTERINE DEVICES MARKET BY 2019-2027 ($ MILLION)

    TABLE 35      ASIA PACIFIC CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

    TABLE 36      JAPAN CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 37      CHINA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 38      INDIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 39      AUSTRALIA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 40      SOUTH KOREA CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

     

    FIGURE LIST

    FIGURE 1      ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 2      ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY EDUCATION 2018 & 2027 (%)

    FIGURE 3      ASIA PACIFIC CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

    FIGURE 4      ASIA PACIFIC CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

    FIGURE 5      ASIA PACIFIC CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

    FIGURE 6      ASIA PACIFIC CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

    FIGURE 7      ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY AGE GROUP 2018 & 2027 (%)

    FIGURE 8      ASIA PACIFIC CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

    FIGURE 9      ASIA PACIFIC CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

    FIGURE 10   ASIA PACIFIC CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

    FIGURE 11   ASIA PACIFIC CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

    FIGURE 12   ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY END-USER 2018 & 2027 (%)

    FIGURE 13   ASIA PACIFIC CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

    FIGURE 14   ASIA PACIFIC CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

    FIGURE 15   ASIA PACIFIC CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

    FIGURE 16   ASIA PACIFIC CONTRACEPTIVE MARKET SHARE BY DRUGS AND DEVICES 2018 & 2027 (%)

    FIGURE 17   ASIA PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

    FIGURE 18   ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

    FIGURE 19   ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

    FIGURE 20   ASIA PACIFIC CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

    FIGURE 21   ASIA PACIFIC CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

    FIGURE 22   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

    FIGURE 23   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

    FIGURE 24   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

    FIGURE 25   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

    FIGURE 26   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

    FIGURE 27   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

    FIGURE 28   ASIA PACIFIC CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 29   ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 30   ASIA PACIFIC INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 31   PORTER’S FIVE FORCE MODEL

    FIGURE 32   JAPAN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 33   CHINA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 34   INDIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 35   AUSTRALIA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 36   SOUTH KOREA CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 37   REST OF ASIA PACIFIC CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • JAPAN
        • CHINA
        • INDIA
        • AUSTRALIA
        • SOUTH KOREA
        • REST OF ASIA PACIFIC
    1. MARKET BY EDUCATION
      • LESS THAN HIGH SCHOOL
      • HIGH SCHOOL GRADUATE
      • COLLEGE GRADUATE
      • OTHER COLLEGE DEGREES
    2. MARKET BY AGE GROUP
      • 15–24 YEARS
      • 25–34 YEARS
      • 35–44 YEARS
      • ABOVE 44 YEARS
    3. MARKET BY END-USER
      • HOUSEHOLDS
      • CLINICS
      • HOSPITALS
    4. MARKET BY DRUGS AND DEVICES
      • CONTRACEPTIVES DRUGS
        • ORAL CONTRACEPTIVE PILLS
        • INJECTABLE CONTRACEPTIVES
        • TOPICAL CONTRACEPTIVES
      • CONTRACEPTIVE DEVICES
        • MALE CONDOMS
        • FEMALE CONDOMS
        • DIAPHRAGMS
        • CONTRACEPTIVE SPONGES
        • VAGINAL RINGS
        • SUBDERMAL IMPLANTS
        • INTRA-UTERINE DEVICES
          • COPPER INTRA-UTERINE DEVICES
          • HORMONAL INTRA-UTERINE DEVICES

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      Get In Touch

      Inquire Before Buying

      Customization

      Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

      Request Customization

      RELATED REPORTS